Our previous study proved that intravenous injection of attenuated Plasmodium can inhibit LLC growth and prolong the survival of tumor-bearing mice by promoting the secretion of IL-6 and IL-12 and inhibiting tumor angiogenesis (Deng et al., 2016). Here, IL6 is linked to neoplasm.